Please wait a minute...
Journal of ZheJiang University(Medical Science)  2015, Vol. 44 Issue (4): 400-409    DOI: 10.3785/j.issn.1008-9292.2015.07.09
    
Effects of miRNA-21 on paclitaxel-resistance in human breast cancer cells
ZHAO Zun-lan1, CAI Ying1, WANG Yang-yang1, XIA Chun-lei2, LI Cong-xin2, CHEN Su-lian3, YANG Qing-ling3, CHEN Chang-jie3
1. Clinical Diagnosis Center, Bengbu Medical College, Bengbu 233000, China;
2. Department of Bioscience, Bengbu Medical College, Bengbu 233000, China;
3. Department of Biochemistry & Molecular Biology, Bengbu Medical College, Bengbu 233000, China
Download:   PDF(1876KB)
Export: BibTeX | EndNote (RIS)      

Abstract  

Objective: To investigate the effects of miR-21 on paclitaxel-resistance in human breast cancer MCF-7/PR and SKBR-3/PR cells. Methods: Paclitaxel-resistant human breast cancer cell lines MCF-7/PR and SKBR-3/PR were established by stepwise selection in increasing concentration of paclitaxel. Cellular morphology, mRNA and protein level of MDR1, BCRP and MRP1 in MCF-7/PR and SKBR-3/PR cells were determined. The expression of Bax, Bcl-2 and miR-21 in parental and paclitaxel-resistant cells was detected by RT-PCR and Western blotting. The synthetic miR-21 inhibitor or miR-21 mimic were transfected into MCF-7/PR, SKBR-3/PR and MCF-7, SKBR-3 cells with Lipofectamine 2000. The miR-21 levels were determined by RT-PCR, and P-gp, Bcl-2 and Bax protein levels were examined by Western blotting. MTT assay was used to measure the cell viability, and flow cytometry was performed to analyze the cell cycle and apoptosis. Results: The levels of MDR1, BCRP, MRP1, Bcl-2/Bax and miR-21 in MCF-7/PR and SKBR-3/PR cells were significantly higher than those in MCF-7 and SKBR-3 cells. The protein levels of P-gp, Bcl-2 were up-regulated, and Bax was down-regulated compared with parental cells. MiR-21 was significantly down-regulated after miR-21 inhibitor was transfected; and the levels of MDR1, BCRP, MRP1 and Bcl-2/Bax (P <0.05) were also down-regulated. MiR-21 inhibitors significantly suppressed G0/G1 transition of the cell cycle, and induced cell apoptosis in MCF-7/PR and SKBR-3/PR cells. MTT results showed that miR-21 inhibitors induced sensitivity of MCF-7/PR and SKBR-3/PR cells to paclitaxel. And miR-21 mimic can increase the expression of MDR1, Bcl-2/Bax and change cell morphology from parental cells to resistant cells. Results: The established MCF-7/PR and SKBR-3/PR breast cancer cells show typical multidrug resistance characteristics, which can be used as the model for drug resistance study. Down-regulated miR-21 expression in MCF-7/PR and SKBR-3/PR breast cancer cells can enhance cell sensitivity to paclitaxel.



Key wordsBreast neoplasms      Paclitaxel/administration &      dosage      MicroRNAs      Drug resistance, neoplasm     
Received: 25 December 2014     
CLC:  R737.9  
Cite this article:

ZHAO Zun-lan, CAI Ying, WANG Yang-yang, XIA Chun-lei, LI Cong-xin, CHEN Su-lian, YANG Qing-ling, CHEN Chang-jie. Effects of miRNA-21 on paclitaxel-resistance in human breast cancer cells. Journal of ZheJiang University(Medical Science), 2015, 44(4): 400-409.

URL:

http://www.zjujournals.com/xueshu/med/10.3785/j.issn.1008-9292.2015.07.09     OR     http://www.zjujournals.com/xueshu/med/Y2015/V44/I4/400


微小RNA-21对人乳腺癌细胞株紫杉醇耐药性的影响及其机制

目的:探讨微小RNA-21 (miR-21)对人乳腺癌细胞MCF-7和SKBR-3及其紫杉醇耐药株细胞生物学活性的影响.方法:体外研究采用紫杉醇逐步加量诱导法建立人乳腺癌细胞紫杉醇耐药株;通过观察细胞形态的变化和检测耐药基因MDR1、BCRP、MRP1的表达以鉴定耐药细胞株;检测MCF-7和SKBR-3亲本及耐药细胞中miR-21和凋亡相关基因Bax、Bcl-2的表达水平;用miR-21抑制剂和模拟物分别转染MCF-7和SKBR-3耐药和亲本细胞株,MTT法和流式细胞术检测转染miR-21 抑制剂后细胞对紫杉醇的敏感程度和细胞周期、凋亡的变化,并检测耐药基因和凋亡相关基因的表达.结果:成功建立人乳腺癌细胞紫杉醇耐药株MCF-7/PR和SKBR-3/PR,耐药细胞株中耐药基因MDR1、BCRP、MRP1表达均升高,抗凋亡基因Bcl-2升高,凋亡基因Bax下降,miR-21表达升高(P <0.05);与对照组比较,miR-21抑制剂可提高耐药细胞株对紫杉醇的药物敏感性,增加细胞凋亡水平,增加细胞周期中G0/G1期细胞(P <0.05),并可抑制耐药细胞株耐药基因的表达,降低Bcl-2/Bax比值(P <0.05),而miR-21 模拟物可刺激亲本细胞出现耐药细胞形态改变,并上调耐药基因的表达及Bcl-2/Bax比值(P <0.05).结论:乳腺癌紫杉醇耐药细胞株MCF-7/PR和SKBR-3/PR中miR-21表达上调;抑制miR-21表达可逆转人乳腺癌MCF-7/PR、SKBR-3/PR细胞株对紫杉醇化疗的耐药性.


关键词: 乳腺肿瘤,  紫杉醇/投药和剂量,  微RNAs,  抗药性,肿瘤 
[[1]]   COCHRANE D R, CITTELLY D M, HOWE E N, et al. MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer [J]. Horm Cancer, 2010,1(6):306-319.
[[2]]   YOSHIMOTO N, TOYAMA T, TAKAHASHI S, et al. Distinct expressions of microRNAs that directly target estrogen receptor alpha in human breast cancer [J] Breast Cancer Res Treat, 2011,130(1):331-339.
[[3]]   NG E K,WONG C L,MA E S,et al. MicroRNAs as new players for diagnosis, prognosis, and therapeutic targets in breast cancer[J]. J Oncol, 2009,2009:305-420.
[[4]]   IORIO M V, FERRACIN M, LIU C G, et al. MicroRNA gene expression deregulation in human breast cancer [J]. Cancer Res, 2005,65(16):7065-7070.
[[5]]   SARKADI B, OZVEGY-LACZKA C, NEMET K, et al. ABCG2-a transporter for all seasons[J]. FEBS Lett, 2004,567(1):116-120.
[[6]]   BARTEL D P. MicroRNAs: genomics, biogenesis, mechanism, and function [J]. Cell, 2004,116(2):281-297.
[[7]]   ALBINSSON S, SUAREZ Y,SKOURA A,et al. MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function[J]. Arterioscler Thromb Vase Biol, 2010,30(6):1118-1126.
[[8]]   WAHID F,SHEHZAD A, KHAN T,et al. MicroRNAs: synthesis,mechanism, function, and recent clinical trials[J]. Biochim Biophys Acta, 2010,1803(11):1231-1243.
[[9]]   NOHATA N,HANAZAWA T,KINOSHITA T,et al. MicroRNAs function as tumor suppressors or oncogenes: aberrant expression of microRNAs in head and neck squamous cell carcinoma[J]. Auris Nasus Larynx, 2013,40(2):143-149.
[[10]]   TIE J,FAN D. Big roles of microRNAs in tumorigenesis and tumor development[J]. Histol Histopathol, 2011,26(10):1353-1361.
[[11]]   YANG W, LEE D Y, BEN-DAVID Y. The roles of microRNAs in tumorigenesis and angiogenesis[J]. Int J Physiol Pathophysiol Pharmacol, 2011,3(2):140-155.
[[12]]   ZHAO R, WU J, JIA W, et al. Plasma miR-221 as a predictive biomarker for chemoresistance in breast cancer patients who previously received neoadjuvant chemotherapy[J]. Onkologie, 2011,34(12):675-680.
[[13]]   CHEN J, TIAN W, CAI H, et al. Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer[J]. Med Oncol, 2012,29(4):2527-2534.
[[14]]   LI Y, ZHU X, GU J, et al.Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis [J].Hematology, 2010,15(4):215-221.
[[15]]   WANG X, LI C, JU S, et al. Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by miRNA-21 up-regulation[J].Leuk Lymphoma,2011,52(10):1991-1998.
[[16]]   陆 晓,孙 婧,高 雯,等.非小细胞肺癌耐药细胞株 A549/DDP 中microRNA 表达的初步研究[J]. 中华肿瘤防治杂志,2010,17(9):660-664. LU Xiao, SUN Jing, GAO Wen, et al. Analysis of microRNAs in drug-resistant NSCLC cell line A549 /DDP. Chinese Journal of Cancer Prevention and Treatment, 2011,52(10):1991-1998. (in Chinese)
[[17]]   TOMINARU Y, EGUCHI H, NAGANO H, et al. MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells[J]. Br J Cancer, 2010,103(10):1617-1626.
[[18]]   缪泽鸿,丁 健.抗肿瘤多药耐药的研究进展[J].癌症,2003, 22(8):886-892. MIAO Ze-hong, DING Jian. Research advances on circumventing tumor multidrug resistance [J]. Chinese Journal of Cancer, 2003,22(8):886-892.(in Chinese)
[[19]]   WANG Z X, LU B B, WANG H, et al. MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN[J].Arch Med Res, 2011,42(4):281-290.
[1] WANG Xiting,TANG Oufeng,YE Yilu,ZHENG Mingzhi,HU Jue,CHEN Zhong,ZHONG Kai. Effects of crocin on hippocampus rapid kindling epilepsy in mice[J]. Journal of ZheJiang University(Medical Science), 2017, 46(1): 7-14.
[2] YANG Xiaohong, YANG Kun, LIAO Li, JIN Yan. Effect of miR-705 on osteogenic differentiation of mouse embryo osteoblast precursor cells MC3T3-E1[J]. Journal of ZheJiang University(Medical Science), 2016, 45(6): 575-580.
[3] GAO Yuhai, YANG Fangfang, XI Huirong, LI Wenyuan, ZHEN Ping, CHEN Keming. Effects of icariin total flavonoids capsule on bone mineral density and bone histomorphometry in growing rats[J]. Journal of ZheJiang University(Medical Science), 2016, 45(6): 581-586.
[4] XIA Guangfa, ZHU Juanying, YUAN Jun, CAO Bo, TANG Jie, CHEN Yiding. Efficacy of adjuvant endocrine therapy in breast cancer patients with a positive-to-negative switch of hormone receptor status after neoadjuvant chemotherapy[J]. Journal of ZheJiang University(Medical Science), 2016, 45(6): 614-619.
[5] WANG Jiesheng, DAI Guanhai, LI Weijia. Berberine regulates glycemia via local inhibition of intestinal dipeptidyl peptidase-Ⅳ[J]. Journal of ZheJiang University(Medical Science), 2016, 45(5): 486-492.
[6] MENG Nannan, HOU Yun, GUI Yan, XI Kehu, WANG Youhu, YANG Jing, CHEN Hong, ZHANG Xiaobing. Effect of methyleugenol on expression of MUC5AC in nasal mucosa of rats with allergic rhinitis[J]. Journal of ZheJiang University(Medical Science), 2016, 45(5): 477-485.
[7] LIN Xiangang, CHEN Yenong, LIU Zhuqing. Effect and its molecular mechanisms of curcumin on pulmonary artery smooth muscle cells in rat model with chronic obstructive pulmonary disease[J]. Journal of ZheJiang University(Medical Science), 2016, 45(5): 469-476.
[8] LIU Jun, HE Xiaole, ZHEN Ping, ZHOU Shenghu, LI Xusheng. Inflammatory cytokines and oxidative stress markers in the inhibition of osteoarthritis by curcumin[J]. Journal of ZheJiang University(Medical Science), 2016, 45(5): 461-468.
[9] CHEN Xiaojing, XU Junfen, YE Jing, CHENG Xiaodong, XIE Xing, LYU Weiguo. Expression of miR-let-7e-3p in cervical intraepithelial neoplasm and cervix carcinoma and its clinical significance[J]. Journal of ZheJiang University(Medical Science), 2016, 45(4): 342-348.
[10] YANG Suwen, WANG Wei, JIN Hong, ZHONG Yuhong, XIE Xinyou. Expression of microRNA-221/222 in patients with monoclonal gammopathy of undetermined significance and multiple myeloma[J]. Journal of ZheJiang University(Medical Science), 2016, 45(4): 371-378.
[11] DING Xia, LI Yan, CUI Yiyi, SHEN Yingying, GU Jianzhong, GUO Yong. Fibromyalgia syndrome after comprehensive treatment of breast cancer: a case report[J]. Journal of ZheJiang University(Medical Science), 2016, 45(4): 429-431.
[12] HAN Rui, WANG Guanying, ZHANG Yujiao, ZHAO Xinhan. Efficacy of neoadjuvant chemotherapy combined with bevacizumab versus neoadjuvant chemotherapy alone for Her2-negative breast cancer: a meta-analysis of randomized controlled clinical trials[J]. Journal of ZheJiang University(Medical Science), 2016, 45(4): 379-386.
[13] CHEN Siteng, YU Lixin, DENG Wenfeng, MIAO Yun, LIU Rumin, YE Guirong. Characteristics of urinary tract infection in kidney transplant recipients and non-recipient patients[J]. Journal of ZheJiang University(Medical Science), 2016, 45(2): 201-207.
[14] WANG Cheng, WANG Wenjun, YANG Wei, YU Xiaohua, YAN Yiguo, ZHANG Jian, JIANG Zhisheng. MicroRNAs: a type of novel regulative factor for intervertebral disc degeneration[J]. Journal of ZheJiang University(Medical Science), 2016, 45(2): 170-178.
[15] WANG Jiaochen, WENG Shouxiang, JIN Xiaofen, YU Wenjie, ZHOU Tao, GAN Meifu. Neuroendocrine differentiation and Wilms' tumor protein-1 expression in breast mucinous carcinoma and their significance[J]. Journal of ZheJiang University(Medical Science), 2016, 45(1): 45-50.